Mowry E - Search Results

1

Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.

Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D. Waubant E, et al. Among authors: mowry e. Arch Neurol. 2009 Aug;66(8):967-71. doi: 10.1001/archneurol.2009.135. Arch Neurol. 2009. PMID: 19667217

2

Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activity.

Bou Rjeily N, Fitzgerald KC, Mowry EM. Bou Rjeily N, et al. Among authors: mowry em. Mult Scler. 2024 Feb;30(2):257-260. doi: 10.1177/13524585231208311. Epub 2023 Nov 9. Mult Scler. 2024. PMID: 37942884 Review.

3

Clinical and radiologic characteristics associated with multiple sclerosis misdiagnosis at a tertiary referral center in the United States.

Wang Y, Bou Rjeily N, Koshorek J, Grkovski R, Aulakh M, Lin D, Solomon AJ, Mowry EM. Wang Y, et al. Mult Scler. 2023 Oct;29(11-12):1428-1436. doi: 10.1177/13524585231196795. Epub 2023 Sep 12. Mult Scler. 2023. PMID: 37698023

4

Serum Sickness/Serum Sickness-like Reactions Following Ocrelizumab Infusion in 2 Patients With Multiple Sclerosis.

Rjeily NB, Nourbakhsh B, Mowry EM. Rjeily NB, et al. Int J MS Care. 2023 Sep-Oct;25(5):196-198. doi: 10.7224/1537-2073.2022-080. Epub 2023 Sep 14. Int J MS Care. 2023. PMID: 37720257 Free PMC article.

5

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.

Gadani SP, Reyes-Mantilla M, Jank L, Harris S, Douglas M, Smith MD, Calabresi PA, Mowry EM, Fitzgerald KC, Bhargava P. Gadani SP, et al. medRxiv [Preprint]. 2021 Aug 25:2021.08.23.21262472. doi: 10.1101/2021.08.23.21262472. medRxiv. 2021. Update in: EBioMedicine. 2021 Nov;73:103636. doi: 10.1016/j.ebiom.2021.103636 PMID: 34462762 Free PMC article. Updated. Preprint.

6

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?

Bou Rjeily N, Mowry EM, Ontaneda D, Carlson AK. Bou Rjeily N, et al. Among authors: mowry em. Neurol Clin. 2024 Feb;42(1):185-201. doi: 10.1016/j.ncl.2023.06.004. Epub 2023 Aug 21. Neurol Clin. 2024. PMID: 37980115 Review.

7

Deep gray matter substructure volumes and depressive symptoms in a large multiple sclerosis cohort.

Hu C, Dewey BE, Mowry EM, Fitzgerald KC. Hu C, et al. Among authors: mowry em. Mult Scler. 2023 Jun;29(7):809-818. doi: 10.1177/13524585221148144. Epub 2023 Jan 24. Mult Scler. 2023. PMID: 36691798 Free PMC article.

8

Quantifying the Association between Objectively Measured Physical Activity and Multiple Sclerosis in the UK Biobank.

Meng Q, Cui E, Leroux A, Mowry EM, Lindquist MA, Crainiceanu CM. Meng Q, et al. Among authors: mowry em. Med Sci Sports Exerc. 2023 Dec 1;55(12):2194-2202. doi: 10.1249/MSS.0000000000003260. Epub 2023 Jul 28. Med Sci Sports Exerc. 2023. PMID: 37535318 Free PMC article.

9

Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?

Chabas D, Castillo-Trivino T, Mowry EM, Strober JB, Glenn OA, Waubant E. Chabas D, et al. Among authors: mowry em. Neurology. 2008 Sep 30;71(14):1090-3. doi: 10.1212/01.wnl.0000326896.66714.ae. Neurology. 2008. PMID: 18824673

10

The onset location of multiple sclerosis predicts the location of subsequent relapses.

Mowry EM, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E. Mowry EM, et al. J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):400-3. doi: 10.1136/jnnp.2008.157305. Epub 2008 Dec 9. J Neurol Neurosurg Psychiatry. 2009. PMID: 19066192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters